EN
HI
Summary
As of 1 Oct, 2026, Shukra Pharmaceuticals stock price is ₹62.09. During the trading session, the stock has moved between an intraday low of ₹60.77 and an intraday high of ₹63.36. Over the last 52 weeks, Shukra Pharmaceuticals has traded between ₹40.06 and ₹63.36.
The stock has recorded a trading volume of 60,37,718 shares,. Its Average Traded Price (ATP) is ₹61.89, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹62.09.
Shukra Pharmaceuticals has an upper circuit limit of ₹72.36 and a lower circuit limit of ₹48.24. The total value traded stands at ₹37.37 CR, and the delivery percentage for the day is 16.55%.
The stock is currently traded with a market lot size of 1. Shukra Pharmaceuticals also offers a dividend yield of 0.02%.
Shukra Pharmaceuticals Share Price Chart
Shukra Pharmaceuticals Share Key Metrics
Volume
60.38 L
Market Cap
2729.57 CR
LTQ@LTP
10@62.09
ATP
61.89
Var Margin
26.77 %
Circuit Range
48.24-72.36
Delivery %
16.55 %
Value
37.37 CR
ASM/GSM
No
Market Lot
1
Shukra Pharmaceuticals Fundamentals
P/E Ratio
120.72
P/B Ratio
0
Div. Yield
0.02
Sector P/E
43.56
Sector P/B
3.67
Sec. Div. Yield
0.51
Shukra Pharmaceuticals Resistance and Support
Pivot 60.6
Resistance
First Resistance
62.2
Second Resistance
64.09
Third Resistance
65.69
Support
First Support
58.71
Second Support
57.11
Third Support
55.22
Shukra Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Sep 30 2026 | 60.96 | 62.09 | 2.99% | 63.36 | 60.77 |
| Tue Sep 29 2026 | 60.25 | 60.29 | 1.45% | 62.49 | 59 |
| Mon Sep 28 2026 | 56.7 | 59.43 | 6.26% | 60.49 | 56 |
Shukra Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-22 | A.G.M. |
| 2025-10-03 | Others |
| 2026-08-12 | Quarterly Results |
| 2026-06-10 | Others |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-03-16 | Others |
| 2026-02-04 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-06-04 | Final Dividend |
| 2025-05-29 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-29 | Stock Split |
| 2025-01-09 | Others |
| 2024-11-14 | Quarterly Results |
| 2024-09-28 | Rights issue of Equity Shares |
| 2024-08-12 | Quarterly Results |
Shukra Pharmaceuticals Management
| Name | Position |
|---|---|
| Dakshesh Rameshchandra Shah | Managing Director |
| Payal Mehta | Executive Director |
Shukra Pharmaceuticals Similar Stocks
Indraprastha Medical Corporation Ltd.
348.95
-5.85 (1.65%)
Kwality Pharmaceuticals Ltd.
3641.40
16.30 (0.45%)
Solara Active Pharma Sciences Ltd.
725.40
-24.45 (3.26%)
Ind-Swift Laboratories Ltd.
388.75
-24.35 (5.89%)
Advanced Enzyme Technologies Ltd.
281.60
-0.55 (0.19%)
Hikal Ltd.
217.89
-0.16 (0.07%)
Dishman Carbogen Amcis Ltd.
157.47
-3.92 (2.43%)
Dr Agarwals Eye Hospital Ltd.
5130.00
0.50 (0.01%)
Sakar Healthcare Ltd.
1093.05
-28.80 (2.57%)
Shukra Pharmaceuticals FAQs
The Buying Price of Shukra Pharmaceuticals share is 62.09 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Shukra Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shukra Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Shukra Pharmaceuticals shares is 120.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Shukra Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Shukra Pharmaceuticals’s valuation compare Sector P/E, P/B which are 43.56 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Shukra Pharmaceuticals is 2729.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Shukra Pharmaceuticals share price is 63.36 & 40.06. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Shukra Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SHUKRAPHAR
Or Download Choice FinX App
Invest in SHUKRAPHAR
